2014
DOI: 10.1016/j.vaccine.2014.02.092
|View full text |Cite
|
Sign up to set email alerts
|

Emergence of antigenic variants of Foot-and-Mouth Disease Virus serotype O in Ecuador and preliminary evaluation of a field strain as a vaccine candidate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 20 publications
0
5
0
Order By: Relevance
“…These viruses diverged in 3 lineages, of which, only one is still present. This study speculates that adequate vaccine protection was not achieved against the current field strain (Maradei et al., , ).…”
Section: Endemic Pools In Africamentioning
confidence: 78%
“…These viruses diverged in 3 lineages, of which, only one is still present. This study speculates that adequate vaccine protection was not achieved against the current field strain (Maradei et al., , ).…”
Section: Endemic Pools In Africamentioning
confidence: 78%
“…In addition, previous studies with FMDV serotype O indicated that cattle with serum titers !1.65 (EPP ! 75%) challenged with heterologous virus were protected [35,36]. Overall VN titers registered in this study were above this threshold.…”
Section: Discussionmentioning
confidence: 48%
“…The observation that the Korean viruses maintained reactivity with two MAbs having the capacity to in vitro neutralize the vaccine strain O 1 /Campos could account for the protective response of the O 1 /Campos against Korean isolates described in this study. Previous reports showed that animals infected with isolates lacking reactivity with these two MAbs required revaccination to attain satisfactory protection [34][35][36].…”
Section: Discussionmentioning
confidence: 99%
“…Interestingly, these strains belonging to the EURO‐SA topotype were not or barely detected even by the polyclonal antigen detection ELISA, but were recognized by another type O MAb (3C8, McCullough et al, 1987) raised against an old European type O vaccine strain. In addition, these viruses have been found to be antigenically different from other serotype O viruses from the O/EURO‐SA topotype (Maradei et al, 2011, 2014).…”
Section: Resultsmentioning
confidence: 94%